-
Parkinson’s Patients Show Elevated Levels of GPNMB Protein in Brain
Alterations in certain types of fat in a brain area called the substantia nigra may result in elevated levels of the GPNMB protein and drive neurodegeneration in Parkinson’s disease patients, according to Harvard researchers. The GPNMB protein has a well-known role in driving tumor progression by suppressing immune responses. The protein is also thought to regulate inflammatory responses associated with neurodegenerative disorders, possibly exerting neuroprotective effects.
Click here to read more about this study.
Did you know about this link between protein in the brain and neurogenerative disorders like Parkinson’s disease?
Sorry, there were no replies found.
Log in to reply.